HealthProves
Symptom-centric view

Therapeutic product effect incomplete

Substances reporting Therapeutic product effect incomplete disproportionately — ranked by ROR.

PainDrug ineffectiveOff label useFatigueDyspnoeaAcute kidney injury
showing 148 of 148
Substance ↓ROR [95% CI]ReportsCategoryLabel
13.0 [10.7–15.7]111algemeennew
37.1 [32.2–42.8]213algemeennew
22.0 [19.2–25.3]216algemeennew
7.1 [4.4–11.7]16algemeennew
16.8 [12.3–22.8]43algemeennew
8.4 [7.3–9.6]196algemeennew
6.9 [6.3–7.5]556algemeennew
3.8 [3.5–4.0]956algemeennew
7.1 [6.0–8.4]132algemeennew
11.3 [11.0–11.6]6,288algemeennew
17.0 [15.6–18.5]580algemeennew
9.3 [9.0–9.6]4,320algemeennew
11.0 [10.0–12.1]434algemeennew
11.0 [10.0–12.1]434algemeennew
17.9 [14.4–22.3]86algemeennew
21.8 [18.2–26.2]123algemeennew
4.0 [2.5–6.4]18algemeennew
2.5 [1.9–3.4]49algemeennew
34.7 [30.1–40.0]215algemeennew
9.8 [8.2–11.7]124algemeennew
22.7 [19.8–26.0]221algemeennew
10.3 [7.8–13.5]52algemeennew
10.4 [10.1–10.7]5,054algemeennew
9.2 [8.8–9.7]1,982algemeennew
7.1 [6.0–8.3]155algemeennew
3.5 [3.3–3.7]1,095algemeennew
3.8 [3.6–4.0]961algemeennew
16.5 [15.3–17.9]643algemeennew
6.3 [3.7–10.8]14algemeennew
3.9 [2.9–5.3]43algemeennew
7.4 [7.2–7.6]10,438algemeennew
6.0 [4.7–7.7]63algemeennew
11.6 [8.7–15.5]48algemeennew
5.5 [3.8–7.9]29algemeennew
22.0 [18.6–26.1]143algemeennew
15.5 [12.9–18.6]122algemeennew
7.6 [5.2–11.1]28algemeennew
5.4 [4.4–6.7]86algemeennew
37.8 [32.8–43.6]213algemeennew
37.8 [32.8–43.6]213algemeennew
37.8 [32.8–43.6]213algemeennew
37.8 [32.8–43.6]213algemeennew
2.8 [2.6–3.1]713algemeennew
6.2 [5.8–6.6]1,077algemeennew
6.6 [5.4–8.1]99algemeennew
5.5 [4.6–6.7]108algemeennew
6.0 [5.3–6.7]291algemeennew
6.0 [5.3–6.7]291algemeennew
8.7 [7.5–10.1]176algemeennew
nicotinamide
Niacinamide
42.3 [37.5–47.8]300longevitynew
16.9 [14.8–19.3]226algemeennew
7.6 [6.6–8.7]210algemeennew
6.5 [5.7–7.5]212algemeennew
11.7 [10.4–13.2]284algemeennew
20.0 [16.7–24.0]126algemeennew
7.3 [6.5–8.2]320algemeennew
7.3 [6.5–8.1]320algemeennew
8.9 [8.5–9.2]3,313algemeennew
7.2 [6.9–7.4]3,869algemeennew
5.4 [5.1–5.7]1,153algemeennew
9.0 [8.5–9.6]1,101algemeennew
37.8 [32.8–43.6]213algemeennew
36.8 [35.7–37.9]5,004algemeennew
6.2 [5.5–7.0]255algemeennew
5.8 [5.1–6.6]255algemeennew
10.0 [8.6–11.6]174algemeennew
10.4 [8.7–12.5]126algemeennew
3.5 [2.4–5.0]29algemeennew
6.4 [5.6–7.3]207algemeennew
5.1 [4.4–5.8]209algemeennew
11.6 [10.4–13.0]321algemeennew
4.0 [3.4–4.6]189algemeennew
10.4 [9.9–11.0]1,303algemeennew
9.2 [8.6–9.9]841algemeennew
15.5 [12.8–18.8]110algemeennew
15.2 [12.8–18.1]135algemeennew
7.8 [6.1–9.9]69algemeennew
6.2 [2.3–16.7]4algemeennew
gold
—
36.2 [33.4–39.2]675algemeennew
5.8 [5.2–6.4]315algemeennew
28.8 [25.1–33.0]224algemeennew
28.3 [24.6–32.4]224algemeennew
3.9 [3.4–4.3]303algemeennew
13.1 [11.2–15.2]171algemeennew
3.8 [2.7–5.2]35algemeennew
11.7 [10.3–13.4]226algemeennew
9.2 [8.9–9.5]3,294algemeennew
8.4 [8.1–8.7]3,318algemeennew
10.3 [9.8–10.8]1,935algemeennew
6.4 [6.1–6.6]2,041algemeennew
13.7 [13.0–14.4]1,529algemeennew
9.4 [9.0–9.8]2,509algemeennew
6.4 [5.3–7.7]118algemeennew
11.8 [10.7–12.9]429algemeennew
7.5 [6.8–8.4]351algemeennew
7.5 [6.7–8.3]347algemeennew
7.5 [6.7–8.3]347algemeennew
9.5 [8.3–10.9]224algemeennew
9.5 [8.3–10.9]224algemeennew
11.3 [10.8–11.9]1,937algemeennew
7.0 [5.8–8.5]105algemeennew
4.7 [4.3–5.3]343algemeennew
11.8 [10.7–12.9]429algemeennew
3.2 [2.4–4.2]47algemeennew
3.2 [2.4–4.2]48algemeennew
4.3 [3.5–5.3]98algemeennew
17.1 [15.1–19.4]263algemeennew
3.2 [2.1–5.1]19algemeennew
73.7 [60.0–90.5]114algemeennew
7.0 [6.1–8.0]219algemeennew
11.7 [10.6–12.9]429algemeennew
10.7 [9.7–11.7]433algemeennew
73.9 [70.7–77.2]2,587algemeennew
22.6 [18.1–28.3]83algemeennew
16.0 [13.7–18.7]173algemeennew
5.9 [5.3–6.6]302algemeennew
6.6 [5.8–7.4]272algemeennew
154.2 [113.4–209.6]62algemeennew
4.1 [3.1–5.5]44algemeennew
8.7 [7.5–10.1]189algemeennew
9.9 [9.5–10.3]2,960algemeennew
8.7 [8.4–9.0]4,333algemeennew
35.2 [30.6–40.6]215algemeennew
7.3 [6.5–8.2]305algemeennew
7.4 [6.6–8.2]305algemeennew
6.8 [6.1–7.6]310algemeennew
5.5 [4.9–6.1]291algemeennew
18.9 [16.7–21.4]263algemeennew
18.9 [16.7–21.4]263algemeennew
11.3 [10.2–12.6]357algemeennew
3.9 [3.5–4.5]246algemeennew
5.9 [5.5–6.3]775algemeennew
5.3 [4.2–6.7]70algemeennew
44.0 [39.1–49.5]318algemeennew
7.4 [7.0–7.7]2,084algemeennew
11.7 [9.5–14.3]93algemeennew
7.2 [5.8–8.8]93algemeennew
7.3 [6.2–8.6]147algemeennew
6.0 [5.1–6.9]169algemeennew
6.0 [5.1–7.0]171algemeennew
11.3 [9.8–12.9]216algemeennew
6.2 [6.0–6.4]5,548algemeennew
6.2 [6.0–6.3]5,557algemeennew
3.2 [2.4–4.2]47algemeennew
7.4 [5.2–10.6]31algemeennew
16.8 [15.0–18.7]340algemeennew
2.9 [2.6–3.4]206algemeennew
3.2 [2.8–3.7]180algemeennew

ROR = reporting odds ratio vs. the full FAERS corpus. A signal is not a cause. Source: openFDA (FAERS).